Marengo Advances TriSTAR Pipeline with Ipsen Collaboration
Cambridge, Massachusetts, August 4, 2026 Marengo Therapeutics has announced a major advancement in its strategic TriSTARâ„¢ collaboration with Ipsen,...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Cambridge, Massachusetts, August 4, 2026 Marengo Therapeutics has announced a major advancement in its strategic TriSTARâ„¢ collaboration with Ipsen,...
New York, New York, August 4, 2026 Nuvation Bio has announced that it will present new subgroup analyses from...
Irvine, California, August 4, 2026 Allergan Aesthetics, an AbbVie company, has announced that the U.S. Food and Drug Administration...
